Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-24-006015

Director sold 10,100 shares at an average $13.51 ($136,454)

  • Director acquired 10,100 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KARABELAS ARGERIS N · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-01 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $3.76 $37,600 21,286 D
2024-08-01 Exercise or conversion : show line 2 in the form 10b5-1 +100 $12.74 $1,274 21,386 D
2024-08-01 Sale : show line 3 in the form 10b5-1 −9,600 $13.45 $129,120 11,786 D
2024-08-01 Sale : show line 4 in the form 10b5-1 −400 $14.59 $5,834 11,386 D
2024-08-01 Sale : show line 5 in the form 10b5-1 −100 $15.00 $1,500 11,286 D
Open-market sales · 10,100 sh · avg $13.51 · $136,454

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-08-01 Exercise or conversion : show line 6 in the form 10b5-1 Stock Options (Right to Buy) −100 1,400 D
2024-08-01 Exercise or conversion : show line 7 in the form 10b5-1 Stock Options (Right to Buy) −10,000 20,000 D
Loading xslF345X05/primarydocument.xml…